Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04697927 · ClinicalTrials.gov registry record

A Study of Risk Factors for the COVID-19 Virus Infection

A clinical trial of COVID-19 Infections in Cancer Patients, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
389
Enrollment target
7
Study locations

NCT04697927: Active study of COVID-19 Infections in Cancer Patients, sponsored by Memorial Sloan Kettering Cancer Center.

NCT04697927 is a study of COVID-19 Infections in Cancer Patients that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 389 participants. The trial reports 7 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04697927, a study of COVID-19 Infections in Cancer Patients, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
389 participants
Enrollment target
7
Study locations

Study Summary

The purpose of this study is to collect information that will help the reasearchers learn more about COVID-19 infections in cancer patients, and to find out about the effects of these infections on cancer treatment and outcomes. The research study involves asking people to complete a series of online questionnaires that include questions about their medical history, lifestyle, and risk factors related to the COVID-19 infection. The study will enroll both MSK patients and their household family members.

Interventions

  • OTHER Questionnaires

Study Locations (7)

New York

  • Memorial Sloan Kettering Commack - Commack
  • Memorial Sloan Kettering Westchester - Harrison
  • Memorial Sloan Kettering Cancer Center - New York
  • Memorial Sloan Kettering Nassau - Rockville Centre

New Jersey

  • Memorial Sloan Kettering Basking Ridge - Basking Ridge
  • Memorial Sloan Kettering Monmouth - Middletown
  • Memorial Sloan Kettering Bergen - Montvale

Trial Details

FieldValue
Enrollment Target 389 participants
Start Date 2020-12-30
Est. Completion 2026-12
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the registry record for NCT04697927 still lists

NCT04697927 is an observational study that tracks outcomes without assigning an intervention. The registered 389 participants enrollment target is mid-sized for trials with a published cap.

The record links to 1 condition, with COVID-19 Infections in Cancer Patients appearing as the primary indexed condition, and to 1 intervention - of which Questionnaires is the first listed.

NCT04697927 lists 7 locations in 2 states (New York, New Jersey).

Frequently Asked Questions

What is clinical trial NCT04697927 about?

NCT04697927 is a clinical study titled "A Study of Risk Factors for the COVID-19 Virus Infection". The purpose of this study is to collect information that will help the reasearchers learn more about COVID-19 infections in cancer patients, and to find out about the effects of these infections on cancer treatment and outcomes. The research study involves asking people to complete a series of onlin...

What is the current status of trial NCT04697927?

This trial is currently active not recruiting. The enrollment target is 389 participants. The study started on 2020-12-30. Estimated completion is 2026-12.

What conditions does trial NCT04697927 study?

This clinical trial studies the following conditions: COVID-19 Infections in Cancer Patients.

What interventions are being tested in trial NCT04697927?

The interventions under investigation include: Questionnaires (OTHER).

Who is sponsoring clinical trial NCT04697927?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04697927 being conducted?

This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05431088 · 389 participants · Phase 2

    A Phase 2/3 Study in Adult and Adolescent Participants With SCD

  • NCT00397111 · 390 participants

    Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders

  • NCT05335928 · 390 participants · Phase 3

    Abatacept in Immune Checkpoint Inhibitor Myocarditis

  • NCT05445960 · 390 participants · NA

    Correlation Between Intraoperative Tourniquet Use and Limb pH, Functional Measures and Patient-reported Outcomes After Ankle Fracture Surgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04697927, the US trial registry maintained by the National Library of Medicine. NCT04697927 (mid enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.